Related Experiment Video
Updated: Jan 7, 2026

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
Published on: February 26, 2018
Systematic Review of Clinical and Imaging Features for Differentiating Pulmonary Tuberculosis and Nontuberculous
Akihiko Goto1, Ishikawa Kentaro1, Taisei Hirakawa1
1Department of Respiratory Medicine, Oita Medical Center, Oita, JPN.
Abstract:
Pulmonary tuberculosis (TB) and nontuberculous mycobacterial pulmonary disease (NTM-PD) often present with similar clinical and radiological features, making accurate differentiation essential. This systematic review aimed to summarize diagnostic features that distinguish pulmonary TB from NTM-PD. A systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines searched PubMed for studies differentiating pulmonary TB from NTM-PD. Eligible studies were screened by pulmonary disease specialists, and data on study design, demographics, and diagnostic factors were extracted. Risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool, and meta-analysis with random-effects models evaluated effect sizes and heterogeneity. A PubMed search identified 847 studies, of which 11 observational studies met the inclusion criteria. Imaging findings were the most commonly distinguishing features, with the absence of bronchiectasis more frequently observed in pulmonary TB. Meta-analysis showed a significant association between the absence of bronchiectasis and TB diagnosis (odds ratio (OR): 0.19; 95% CI: 0.10-0.36; I² = 82%). Three studies also reported that positive interferon-gamma release assay (IGRA) results were significantly associated with pulmonary TB (OR: 17.34; 95% CI: 6.71-44.75; I² = 68%). In addition, pulmonary TB was more frequently associated with upper lobe opacities and less involvement of the right middle lobe than NTM-PD. These findings reveal that radiological patterns and the IGRA results may serve as useful markers for differentiating pulmonary TB and NTM-PD. Further large-scale studies are required to validate these findings.
More Related Videos
06:52Optimized Workflow for Iterative Bleaching Extends Multiplexity Imaging of Highly Autofluorescent Clinical Samples
Published on: July 11, 2025
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History